Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 7,990	$ 1,907
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	1,221	1,263
Stock-based compensation expense	5,420	4,518
Provision for bad debt		18
Unrealized foreign currency transaction (gains) losses	35	(4)
Changes in operating assets and liabilities:
Accounts receivable	(457)	(17,123)
Prepaid expenses and other current assets	496	972
Commissions receivable, current and non-current	1,014	1,323
Operating lease right-of-use assets	267	497
Accounts payable	(2,765)	15,868
Accrued expenses and other current liabilities	10,018	1,870
Deferred revenue	335	(2)
Operating lease liabilities	(268)	(667)
Net cash provided by operating activities	23,306	10,440
Cash flows from investing activities:
Acquisition of property and equipment, including costs capitalized for development of internal-use software	(1,133)	(770)
Net cash used in investing activities	(1,133)	(770)
Cash flows from financing activities:
Proceeds from exercise of stock options	1,962	1,428
Tax withholding payments related to net share settlement	(1,293)	(429)
Net cash provided by financing activities	669	999
Effect of exchange rate changes on cash, cash equivalents and restricted cash	10	(5)
Net increase in cash, cash equivalents and restricted cash	22,852	10,664
Cash, cash equivalents and restricted cash at beginning of period	102,116	37,956
Cash, cash equivalents and restricted cash at end of period	124,968	48,620
Supplemental disclosure of non-cash investing information:
Acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities	$ 208	$ 25